logo

For the Inventor, By the Inventor

Staten Island, NY, United States of America

Henry Joshua

USPTO Granted Patents = 13


Average Co-Inventor Count = 2.5

ph-index = 10

Forward Citations = 184(Granted Patents)


Location History:

  • Elizabeth, NJ (US) (1982)
  • Staten Island, NY (US) (1981 - 1994)

Company Filing History:

goldMedal11 out of 4,770 
 
Merck + Co., Inc.
 patents
silverMedal2 out of 832,718 
Other
 patents

Years Active: 1981-1994

Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents
1. 5286895 - Cholesterol lowering compounds (1994-02-15),
2. 5262435 - Cholesterol lowering compounds (1993-11-16),
3. 5202309 - Antibiotic cyclopeptide fermentation product (1993-04-13),
4. 5064856 - Novel HMG-CoA synthase inhibitors (1991-11-12),
5. 5021453 - 3-keto HMG-CoA reductase inhibitors (1991-06-04),
6. 4968693 - 3-keto HMG-COA reductase inhibitors (1990-11-06),
7. 4966695 - High pressure liquid chromatography column jacket (1990-10-30),
8. 4714711 - 6-hydroxy-2(2-hydroxy-4-methoxyphenyl)benzofuran derivatives to inhibit (1987-12-22),
9. 4704400 - Medicarpin derivatives and analogs (1987-11-03),
10. 4523934 - Filter-degasser (1985-06-18),
11. 4420491 - Hypocholesteremic fermentation products and process of preparation (1983-12-13),
12. 4339453 - Antimicrobial aminopyrimidinium salts (1982-07-13),
13. 4294846 - Hypocholesteremic fermentation products and products of preparation (1981-10-13),

Title: The Innovations of Henry Joshua

Introduction

Henry Joshua is a notable inventor based in Staten Island, NY (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of cholesterol-lowering compounds. With a total of 13 patents to his name, his work has had a considerable impact on medical treatments for hypercholesterolemia.

Latest Patents

Among his latest patents, Joshua has isolated an acyclic tricarboxylic compound from a culture of MF5453. This compound and its derivatives are recognized as active squalene synthetase inhibitors, proving useful in the treatment of hypercholesterolemia. Additionally, he has developed a new Zaragozic acid analog, also isolated from a culture of MF5453, which shares similar properties and applications in lowering cholesterol levels.

Career Highlights

Throughout his career, Henry Joshua has worked with prominent companies, including Merck & Company, Inc. His innovative research and dedication to improving health outcomes have established him as a respected figure in the pharmaceutical industry.

Collaborations

Joshua has collaborated with notable colleagues such as George E Albers-Schonberg and Maria B Lopez. Their combined expertise has contributed to the advancement of research in cholesterol-lowering treatments.

Conclusion

Henry Joshua's contributions to the field of pharmaceuticals, particularly in cholesterol-lowering compounds, highlight his role as a significant inventor. His work continues to influence medical treatments and improve patient health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…